A candidate regulatory variant at the TREM gene cluster associates with decreased Alzheimer's disease risk and increased TREML1 and TREM2 brain gene expression
暂无分享,去创建一个
Asha A. Nair | Charles C. White | N. Price | D. Bennett | D. Serie | Y. Asmann | R. Petersen | S. Lincoln | D. Dickson | K. Morgan | M. Carrasquillo | S. Younkin | J. Siuda | C. Medway | P. D. Jager | N. Graff-Radford | M. Allen | C. Younkin | Xue Wang | T. Golde | N. Ertekin-Taner | C. White | A. Nair | Samantha L. Strickland | J. Crook | Kimberly G. Malphrus | J. Burgess | Chen Wang | Shivani Aryal | Pritha Chanana | Michaela Kachadoorian | P. L. Jager | Thuy T. Nguyen | Thuy Nguyen
[1] Manolis Kellis,et al. HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease , 2015, Nucleic Acids Res..
[2] D. Rujescu,et al. The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease , 2015, Alzheimer's & Dementia.
[3] Guiyou Liu. No association of TREM1 rs6910730 and TREM2 rs7759295 with Alzheimer disease , 2015, Annals of neurology.
[4] R. Tanzi. TREM2 and Risk of Alzheimer's Disease--Friend or Foe? , 2015, The New England journal of medicine.
[5] R. Ransohoff,et al. TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer’s disease mouse models , 2015, The Journal of experimental medicine.
[6] Charles C. White,et al. A TREM1 variant alters the accumulation of Alzheimer‐related amyloid pathology , 2015, Annals of neurology.
[7] D. Holtzman,et al. TREM2 lipid sensing sustains microglia response in an Alzheimer’s disease model , 2015, Cell.
[8] L. Lue,et al. TREM2 Protein Expression Changes Correlate with Alzheimer's Disease Neurodegenerative Pathologies in Post‐Mortem Temporal Cortices , 2014, Brain pathology.
[9] F. Jessen,et al. The rare TREM2 R47H variant exerts only a modest effect on Alzheimer disease risk , 2014, Neurology.
[10] T. Maniatis,et al. An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex , 2014, The Journal of Neuroscience.
[11] J. Molinuevo,et al. TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis , 2014, Science Translational Medicine.
[12] Michelle K. Lupton,et al. Missense variant in TREML2 protects against Alzheimer's disease , 2014, Neurobiology of Aging.
[13] R. Kacimi,et al. Abstract 9: Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) deficiency Attenuates Phagocytic Activities of Microglia and Exacerbates Ischemic Damage in Experimental Stroke , 2014, Stroke.
[14] M. Bullido,et al. Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia , 2014, Neurobiology of Aging.
[15] Jennifer M. Pocock,et al. Insights into TREM2 biology by network analysis of human brain gene expression data , 2013, Neurobiology of Aging.
[16] Mark T. W. Ebbert,et al. Assessment of TREM2 rs75932628 association with Alzheimer's disease in a population-based sample: the Cache County Study , 2013, Neurobiology of Aging.
[17] Nick C Fox,et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.
[18] C. Cruchaga,et al. TREM2 is associated with the risk of Alzheimer's disease in Spanish population , 2013, Neurobiology of Aging.
[19] Matthew H. Bailey,et al. GWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer’s Disease , 2013, Neuron.
[20] A. Singleton,et al. TREM2 variants in Alzheimer's disease. , 2013, The New England journal of medicine.
[21] A. Hofman,et al. Variant of TREM2 associated with the risk of Alzheimer's disease. , 2013, The New England journal of medicine.
[22] Eurie L. Hong,et al. Annotation of functional variation in personal genomes using RegulomeDB , 2012, Genome research.
[23] J. Schneider,et al. Overview and findings from the religious orders study. , 2012, Current Alzheimer research.
[24] Margaret A. Pericak-Vance,et al. Brain Expression Genome-Wide Association Study (eGWAS) Identifies Human Disease-Associated Variants , 2012, PLoS genetics.
[25] F. Massin,et al. Soluble Trem-like Transcript-1 Regulates Leukocyte Activation and Controls Microbial Sepsis , 2012, The Journal of Immunology.
[26] K. Sakamoto,et al. The Role of the Transcription Factor CREB in Immune Function , 2010, The Journal of Immunology.
[27] T. Mikkelsen,et al. The NIH Roadmap Epigenomics Mapping Consortium , 2010, Nature Biotechnology.
[28] Yun Li,et al. METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..
[29] A. Dutra,et al. TREM-like transcript-1 protects against inflammation-associated hemorrhage by facilitating platelet aggregation in mice and humans. , 2009, The Journal of clinical investigation.
[30] D. McVicar,et al. TREM and TREM-like receptors in inflammation and disease. , 2009, Current opinion in immunology.
[31] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[32] J. Plutzky,et al. Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets. , 2007, Circulation.
[33] Brantley R. Herrin,et al. Trem-Like Transcript 2 Is Expressed on Cells of the Myeloid/Granuloid and B Lymphoid Lineage and Is Up-Regulated in Response to Inflammation , 2006, The Journal of Immunology.
[34] David A. Bennett,et al. The Rush Memory and Aging Project: Study Design and Baseline Characteristics of the Study Cohort , 2005, Neuroepidemiology.
[35] Edward H. Cho,et al. A TREM family member, TLT-1, is found exclusively in the alpha-granules of megakaryocytes and platelets. , 2004, Blood.
[36] D. Campion,et al. TREM2 R47H variant as a risk factor for early-onset Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.